Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice

Abstract The clinical development of an effective Chlamydia vaccine requires in-depth understanding of how well protective pre-clinical immune signatures translate to humans. Here, we report a comparative immunological characterization of CTH522/CAF®01 in female mice and humans. We find a range of i...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anja W. Olsen, Ida Rosenkrands, Christina S. Jacobsen, Hannah M. Cheeseman, Max P. Kristiansen, Jes Dietrich, Robin J. Shattock, Frank Follmann
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2024-02-01
Col·lecció:	Nature Communications
Accés en línia:	https://doi.org/10.1038/s41467-024-45526-2
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!